Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on January 02, 2019, 10:39:38 am
-
Gilead Sciences’ Harvoni (ledipasvir/sofosbuvir) is safe and well tolerated when dosed according to weight among children between age 3 and just shy of 6.
Presenting their findings at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco, researchers enrolled 34 children who were older than 3 years old but who had not yet reached their sixth birthday in a study of weight-based dosing of Harvoni.
Read more...
https://www.hepmag.com/article/harvoni-safe-3-5yearolds-hepatitis-c